Table: Kohjin Bio -Q1 group results

Kohjin Bio

14/08/2026 07:00

    Aug 14 (Reuters)- 
             Kohjin Bio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            974 mln              1.22             4.72     
                 (-20.1 pct)         (-1.8 pct)       (-4.4 pct)  
  Operating      loss 54 mln           131 mln          137 mln   
                                     (-36.6 pct)      (-59.8 pct) 
  Recurring      loss 36 mln           116 mln          147 mln   
                                     (-48.4 pct)      (-56.8 pct) 
  Net            loss 41 mln           82 mln           110 mln   
                                     (-49.4 pct)      (-55.9 pct) 
  EPS           loss 8.20 yen         16.10 yen        21.65 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Kohjin Bio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=177A.T